Pragmatism in practice: lessons learned during screening and enrollment for a randomised controlled trial in rural northern Ethiopiaby Meseret Molla, Henok Negussie, Moses Ngari, Esther Kivaya, Patricia Njuguna, Fikre Enqueselassie, James A. Berkley, Gail Davey
We use the example of the Gojjam Lymphoedema Best Practice Trial (GoLBeT), a pragmatic trial in a remote rural setting in northern Ethiopia, to extract lessons relevant to other investigators balancing the demands of practicality and community acceptability with internal and external validity in clinical trials.
Interview with Sr Brenda Wright, clinical research nurse-turned book author/editorby GRN coordinator
Scoping available resources and tools - WWARN surveyby Clifford Banda
Scoping available resources and tools used by investigators to set up and conduct malaria clinical trials in low and middle income countries within malaria endemic settings. Participate in the survey.
This short film shows the impact of the CHAPAS trial on patient health and future possibilities of a small boy from Malawi.
PAPER - an assessment of how adverse events from clinical trials are reported in published papersby Global Pharmacovigilance
A recently published paper in PLOS Medicine has investigated how adverse event data from clinical trials are summarised and consequently reported in published papers.
The European Mobile Laboratory, EMLab, was the first EBOV diagnostics unit deployed to the outbreak epicentre by WHO in March 2014.
Recent calls have been made for rapid and responsible sharing of research data in public health emergencies and outbreaks.
Trial design for evaluating novel treatments during an outbreak of an infectious diseaseby John Whitehead, Piero Olliaro, Trudie Lang , Peter Horby
This article discusses the designs used for two such clinical trials which have recruited patients in Liberia and Sierra Leone. General principles are outlined for trial designs intended to be deployed quickly, adapt flexibly and provide results soon enough to influence the course of the current epidemic rather than just providing evidence for use should Ebola break out again. Lessons are drawn for the conduct of clinical research in future outbreaks of infectious diseases, where the sequence of events may or may not be similar to the West African Ebola epidemic. The paper was published in Clinical Trials.
Research Nurse Jerome Ackeneck discusses what's involved in his role on a Cameroonian HIV Study
Anders Björkman is Professor of Infectious Disease at the Karolinska Institute. In this video, Anders talks about how the efficacy of antimalarials is a major obstacle in the path towards full malaria elimination.
Are you a research scientist working in Global Health? Or an institution looking for partners to run a clinical trial? Site Finder is for you.
In this seminar from January 2014, Dr Jane Crawley talks about clinical standardisation in PERCH (Pneumonia Etiology Research for Child Health), a large case-control study of the causes of and risk factors for severe pneumonia.
Professor Bongani M Mayosi from the Department of Medicine, Groote Schuur Hospital & University of Cape Town describes the transofmation of the science cohort in South Africa.
In celebration of Global Health Trials' fifth birthday (May 11th 2015) Professor Trudie Lang, Principal Investigator of the programme, talks to us about why Global Health Trials was started, why people should share their experience, and what the future holds.
We repeated, 10 years apart, the retrospective treatment-outcome study on 400 children with presumed malaria in the same area (Argemone mexicana decoction).
Global Health Technologies Pooled Funding Webinar Summary Reportby Global Health Technologies Coalition
How to Make More Published Research Trueby John P. A. Ioannidis
Bayesian Clinical Trials (Nature Reviews Article)by Donald A. Berry
An introduction into and overview on the mathematics and practice of Bayesian (adaptive) clinical trials.
A “reverse pharmacology” approach for developing an anti-malarial phytomedicineby Merlin Willcox, Bertrand Graz, Jacques Falquet, Chiaka Diakité, Sergio Giani, Drissa Diallo
A new "improved traditional medicine" for malaria was developed in Mali, using an innovative approach. Instead of starting with classical laboratory research on plant phytochemistry and pharmacology, the authors first observed the clinical effectiveness of herbal remedies in current use. This approach enabled them to select what appeared to be the most effective remedy among 66 others.
Clinical Research Laboratories for Trials in Global Health in Central Africaby ALI Innocent, akindeh, Prof Wilfred F. Mbacham
The authors present the story of building a succesful research laboratory in Cameroon, including how they managed building up the infrastructure, equipment maintenance, staff training.